Acquisition of Musculoskeletal System Medications for the Treatment of Endocrine Diseases and Hormones 2

This tender concerns the procurement of medications specifically for the musculoskeletal system. These pharmaceuticals are intended for the treatment of endocrine diseases and hormone-related conditions. The scope of the acquisition includes a range of drugs designed to address conditions affecting bones, joints, muscles, and related tissues, as well as those that regulate hormonal balance within the body. The tender is likely issued by a healthcare provider, hospital, or public health authority seeking to ensure an adequate supply of these specialized treatments for patient care. The specific designation '2' suggests this may be a continuation or a second phase of a previous procurement effort for similar medical supplies. The objective is to secure high-quality, effective medications to meet the therapeutic needs of patients suffering from complex endocrine and hormonal disorders that also impact their musculoskeletal health.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 29,265.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.